Thromboxane A2 Receptor Activates a Rho-associated Kinase/LKB1/PTEN Pathway to Attenuate Endothelium Insulin Signaling
Open Access
- 19 June 2009
- journal article
- retraction
- Published by Elsevier BV
- Vol. 284 (25), 17120-17128
- https://doi.org/10.1074/jbc.m109.012583
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular DamageDiabetes, 2009
- Vascular Inflammation, Insulin Resistance, and Reduced Nitric Oxide Production Precede the Onset of Peripheral Insulin ResistanceArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Protein Kinase Cζ-dependent LKB1 Serine 428 Phosphorylation Increases LKB1 Nucleus Export and Apoptosis in Endothelial CellsPublished by Elsevier BV ,2008
- Thromboxane Receptor Activates the AMP-Activated Protein Kinase in Vascular Smooth Muscle Cells via Hydrogen PeroxideCirculation Research, 2008
- Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infectionThe Journal of Experimental Medicine, 2007
- Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery DiseaseCirculation Research, 2006
- Skeletal Muscle-Selective Knockout of LKB1 Increases Insulin Sensitivity, Improves Glucose Homeostasis, and Decreases TRB3Molecular and Cellular Biology, 2006
- The Thromboxane A 2 Receptor Antagonist S18886 Prevents Enhanced Atherogenesis Caused by Diabetes MellitusCirculation, 2005
- Involvement of Actin in Agonist-induced Endocytosis of the G Protein-coupled Receptor for Thromboxane A2: OVERCOMING OF ACTIN DISRUPTION BY ARRESTIN-3 BUT NOT ARRESTIN-2Published by Elsevier BV ,2005
- The Tumor Suppressor PTEN Is Phosphorylated by the Protein Kinase CK2 at Its C Terminus: IMPLICATIONS FOR PTEN STABILITY TO PROTEASOME-MEDIATED DEGRADATIONJournal of Biological Chemistry, 2001